A clinical trail to study effect of Grewia serrrulata DC. oil and shampoo in dandruff

Pharmacognostical pharmaceutical analytical and clinical study of Grewia serrulata DC. WSR to Darunaka (dandruff)- A folklore claim

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/06/043617

Enrollment

Registered

2022-06-30

Start date

Unknown

Completion date

Unknown

Last updated

2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere Health Condition 2: L80-L99- Other disorders of the skin and subcutaneous tissue

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients with signs and symptoms of Darunaka

Exclusion criteria

Exclusion criteria: Patients suffering from known case of : 1 Allergic manifestation 2 Psycological diseases 3 Alopecia

Design outcomes

Primary

Measure	Time frame
The effect of treatment will be assessed based on detailed case proforma adopting standard scoring methods of subjective parameters such as Kandu, keshachyuti and objective parameters such as Roukshya and Sa Sookshma Sphutanam Twacha. Assessment will be done at baseline, 7th 14th 21st 28th day and then onwards patient will be assessed once in 14 days for 8 weeksTimepoint: The effect of treatment will be assessed based on detailed case proforma adopting standard scoring methods of subjective parameters Assessment will be done at baseline, 7th 14th 21st 28th day and then onwards patient will be assessed once in 14 days for 8 weeks	—

Measure

Time frame

The effect of treatment will be assessed based on detailed case proforma adopting standard scoring methods of subjective parameters such as Kandu, keshachyuti and objective parameters such as Roukshya and Sa Sookshma Sphutanam Twacha. Assessment will be done at baseline, 7th 14th 21st 28th day and then onwards patient will be assessed once in 14 days for 8 weeksTimepoint: The effect of treatment will be assessed based on detailed case proforma adopting standard scoring methods of subjective parameters Assessment will be done at baseline, 7th 14th 21st 28th day and then onwards patient will be assessed once in 14 days for 8 weeks

—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr subrahmanya P

Alvas Ayurveda Medical College

drsp28@gmail.com9448327156

Outcome results